Resource-sparing and cost-effective strategies in current management of breast cancer

被引：6

作者：

Munshi, Anusheel ^{[1
]}

机构：

[1] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India

来源：

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 2009年 / 5卷 / 02期

关键词：

Breast cancer; resource sparing; cost effective; ADJUVANT CHEMOTHERAPY; PREMENOPAUSAL PATIENTS; POSTMENOPAUSAL WOMEN; CONSERVING THERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; TAMOXIFEN; TRASTUZUMAB; LONG; RADIOTHERAPY;

D O I：

10.4103/0973-1482.52797

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is the leading cause of death in women throughout the world. There have been significant advances in the practice of breast oncology over the past few years. However, most of these advances have an associated price tag or are resource intensive. The present article discusses means to achieve cost-effectiveness in the treatment of breast cancer, while retaining the benefits of the modern anticancer approaches.

引用

页码：116 / 120

页数：5

共 44 条

[1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2] Use of radiation treatment units in breast cancer.: Changes in the last 15 years
Algara Lopez, Manuel
Sanz Latiesas, Xavier
Foro Arnalot, Palmira
Lacruz Bassols, Marti
Reig Castillejo, Anna
Lozano Galan, Joan
Membrive Conejo, Ismael
Quera Jordana, Jaume
Rodriguez de Dios, Nuria
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (01) : 47 - 51
[3] [Anonymous], 1993, Lancet, V341, P1293
[4] Adjuvant trastuzumab: A milestone in the treatment of HER-2-positive early breast cancer
Baselga, Jose
Perez, Edith A.
Pienkowski, Tadeusz
Bell, Richard
[J]. ONCOLOGIST, 2006, 11 : 4 - 12
[5] Baum M, 2002, LANCET, V359, P2131
[6] Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial
Castiglione-Gertsch, M
O'Neill, A
Price, KN
Goldhirsch, A
Coates, AS
Colleoni, M
Nasi, ML
Bonetti, M
Gelber, RD
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24): : 1833 - 1846
[7] Three-week accelerated radiation therapy (ART) schedule with a concomitant in-field boost as treatment for early stage breast cancer
Chadha, M.
Woode, R.
Sillanpaa, J.
Feldman, S.
Boolbol, S.
Furhang, E.
Harrison, L. B.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S137 - S137
[8] The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry
Chen, SQ
Chou, WH
Blouin, RA
Mao, ZP
Humphries, LL
Meek, C
Neill, JR
Martin, WL
Hays, LR
Wedlund, PJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (05) : 522 - 534
[9] Long-term medical costs of postmenopausal breast cancer therapy
Cocquyt, V
Moeremans, K
Annemans, L
Clarys, P
Van Belle, S
[J]. ANNALS OF ONCOLOGY, 2003, 14 (07) : 1057 - 1063
[10] Cohen EE, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.12.0758

← 1 2 3 4 5 →